Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Alternatives to Laboratory Animals : ATLA|May 29, 2010
Prevalidation of the rat CFU-GM assay for in vitro toxicology applicationsAugusto Pessina, Arianna Bonomi, Loredana Cavicchini, et al.
Histopathology|June 16, 2010
Reproducibility in the diagnosis of needle core biopsies of non-palpable breast lesions: an international study using virtual slides published on the world-wide webFrancesco Alfredo Zito, Paolo Verderio, Giovanni Simone, et al.
Clinical Chemistry|June 22, 2007
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplificationClaudio Orlando, Paolo Verderio, Ronald Maatman, et al.
Genes, Chromosomes & Cancer|March 13, 2012
Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapseDaniela Perotti, Filippo Spreafico, Federica Torri, et al.
Scientific Reports|January 31, 2024
A gene expression-based classifier for HER2-low breast cancerSerena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, et al.
Clinical Breast Cancer|August 29, 2024
Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the BreastChiara M Ciniselli, Paolo Verderio, Paolo Baili, et al.
Breast Cancer Research and Treatment|July 24, 2010
The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriersIrene Catucci, Paolo Verderio, Sara Pizzamiglio, et al.
Frontiers in Oncology|February 17, 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTOSerena Di Cosimo, Chiara M Ciniselli, Sara Pizzamiglio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2019
Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO TrialSerena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, et al.
Cancer|May 19, 2012
Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapySilvia Stacchiotti, Paolo Verderio, Antonella Messina, et al.
Pageof 7